ABSTRACT
INTRODUCTION
Tuberculosis is one of the major global health care issues, caused by the infection of Mycobacterium tuberculosis. M.tuberculosis has about 4111 genes in the circular genome of size 4.4 Mb and 65% of GC content (Schürch AC, et al., 2010) . Almost One third of the human population was being affected by M.tuberculosis of which a major population is from developing countries (Lönnroth K, et al., 2010) . Due to inadequate administration and prolonged use of the first-line treatment drugs like isoniazid rifampicin, ethambutol and streptomycin (VanderWerf MJ, et al., 2012 )the emergence of Multidrug resistance in M.tuberculosis strains have been observed around the world with high mortality rates among HIV-positive patients (Jacobs RF, 1994) . Improved MDR scenario in M.tuberculosis is also emerging in HIV negative populations (vanRie A, et al., 1999) . According to WHO 3.7% of the new cases of the previously treated patients have been infected with the multidrug-resistant (MDR) M.tuberculosis The reason behind this drug resistance is the primary transmission which is a growing concern in recent days (Zhao Y, et al., 2012) . The above mentioned serious concerns has leads to the development of new anti-tubercular drugs. The internal resistance of M.tuberculosis is due to several factors such as active drug efflux mechanism, highly permeable mycolic acid containing cell wall and the production of drug modifying and drug inactivating enzymes (Ramaswamy S, et al., 1998) . M.tuberculosis contains unique signature fatty acids and mycolic acids that are unusually long chain α-alkyl and β-hydroxy fatty acids of 60-90 carbons (Takayama K, et al., 2005) . Mycolic acids are the central constituents of the mycobacterial cell wall and the biosynthesis of mycolic acid involves several successive enzymatic reactions involving two enzyme systems FAS-I (Fatty acid Synthase -I) and FAS-II (Fatty acid Synthase -II). In the present study InhA protein a part of Fatty acid Synthase system was selected as a novel drug target. Plant derived phytochemicals have been traditionally used as natural remedy in treatment of diverse ailments. Usage of medicinal plants demonstrate promising and potential effect in treatment against many human diseases (Ronaldo . In this content there is an interest in developing novel lead molecules from plant sources . Garlic (Allium sativum) is a potent medicinal plant widely used as a food item and folk medical treatment for hundreds of years, globally (Rivlin RS, 2001) . Garlic is reported to have powerful biological characteristics such antioxidant, antimicrobial, hypoglycemic, anti-cancer, antiinflammatory, immunomodulatory and anticardiovascular effects (Reuter HD, et al., 1996) . Various garlic herb extracts have shown highly effective activity against Gram-positive and Gram-negative bacteria such as different strains of Escherichia, Bacillus, Clostridium, Klebsiella, Salmonella, Proteus, Staphylococcus, Streptococcus, Helicobacter pylori (Cellini L, et al., 1996) possibly even acid-fast bacilli (AFB) like MTB (Uchida Y, et al., 1975) . In this study, we aim at exploring novel phytoconstituents from A.sativum as potential lead molecules against the target protein enoyl-ACP reductase (InhA) using Molegro Virtual Docker.
MATERIALS AND METHODS

Ligand Preparation
The structure of different phytochemicals from A.sativum were retrieved from Pubchem (https://pubchem.ncbi.nlm.nih.gov/) and Chemspider database (http://www.chemspider.com/). The compounds were converted into compatible format (.sdf) using Open Babel tool. The root mean square gradient value was selected less than 0.001 kcal/mol. The energy minimized structure was used for docking studies.
Protein Preparation
The three dimensional crystal structure of the protein enoyl-ACP reductase was retained from Protein DataBank (http://www.rcsb.org/pdb/). The bonds, bond orders, explicit hydrogen, charges (calculated by MVD), flexible torsion and Tripos atom types were assigned if they were missing by using 'Protein Preparation' module of Molegro Virtual Docker for the protein enoyl-ACP reductase.
Molecular Docking
Molgro virtual docking computer program relies upon the innovative hybrid search technique referred to as guided differential evaluation. Docking was carried out applying a grid resolution of 0.30 Å and for all of the 5 independent runs; the highest possible amount of 1,500 iterations were carried out on a single population of 50 individuals. The active binding location was regarded as a rigid molecule, however the ligands were regarded to be flexible, i.e. any non-ring torsions were permitted. Default configurations were employed for every calculation.
Phyto-constituents from A.sativum (Table 1 
RESULTS AND DISCUSSIONS
Natural products and some of their derivatives have shown promising activity against M.tuberclosis highlighting their potential as a powerful source of new class of drugs. A number of genetic mutation were seen to have taken place generally between codons 138 and 328. The Ser315Thr mutation is most frequent and present in more than 40% of every INH resistant strains. These strains needs to be targeted with potent drug molecues to attain the best possible medicinal effects. Therefore, In the present study library of natural compounds from A.sativum has been screened against enoyl-ACP reductase and concluded our results using average binding affinity of these compounds against them. The selected phytocompounds from A.sativum has shown potent binding affinity against enoyl-ACP reductase.
Prediction of Binding site
Detection of cavities is the more important step in the protein-ligand interaction. The cavities present in the protein enoyl-ACP reductase is detected based on the cavity detection algorithm in MVD tool (Thomsen R, et al., 2006) . The volume of the cavities is listed in Table 2 . In most cases, the cavities with the largest size and volume is associated with the binding site. Cavity 2 and Cavity 3 have the larger volume of 928.256 Å 3 " (Fig. 1 A) " and 501.248 Å 3 " (Fig. 1 B) " respectively. The cavity with larger size has been selected as the binding site for the protein enoyl-ACP reductase during docking with Molgro Virtual Docker " (Fig. 2) ". 
Molecular Docking
In recent scenario, computational methods such as molecular docking tools are used to design novel lead molecules by exploring the interaction between the protein and the ligand molecules (Srivastava, et al., 2010) . The docking analysis of the selected phyto-compounds from A.sativum with the protein enoyl-ACP reductase was performed using MVD. The inhibition susceptibility was determined using moldock score which was generated by MVD. The receptor bound ligand was docked deeply in binding pocket region by strong interaction. The active compound Ajoene binds with the receptor with a moldock score of -80.6047 (Table 3) . It binds to the Ile -257 amino acid in the cavity 2 (Fig. 3 A) and has only one Hydrogen bond interaction. Allin expressed a hydrogen bond score of -9.707
Kcal/mol and with four amino acid interactions at different domains of the target protein " (Fig. 3 B) ". Ascorbic acid had a moldock score of -71.4068 Kcal/mol and the hydrogen bond interactions were high as compared to that of Ajoene. Compounds such as methylallyl trisulfide and diallyl shows very less Moldock score and hence have a very less affinity for the target. The H-Bond score for Ascorbic acid was -14.5056 Kcal/mol. There are 9 amino acid residues from different domains of enoyl-ACP reductase involved in interaction with Ascorbic acid " (Fig. 3  C) ". Scorodonin had four hydrogen bond interaction with 2 amino acid residues " (Fig. 3 D) ". 
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The rate limiting step and final step Mycobacterium Enoyl-ACP reductase catalyzes the final step and rate limiting step in the fatty acid synthesis (mycolic acid) by utilizing NADH to reduce trans double bond of longer fatty acyl substrates (Moir DT, 2005 , Rozwarski DA, et al., 1998 and are validated as the excellent target for drug development against M.tuberculosis (Yamada H, et al., 1995) . The replacement of an amino acid in the NADH binding site of InhA apparently results in INH resistance, preventing the inhibition of mycolic acid biosynthesis (Zhang YM, et al., 2006) . Various genetic mutations have been observed to occur usually between codons 138 and 328 (Ramaswamy S, et al., 1998) . The Ser-315-Thr mutation is most frequent and found in about 40% of all INH-resistant strains (Marttila HJ, et al., 1998 , Zhang YM, et al., 2006 . The mutation leads to the enzyme lacking the ability to activate INH, but preserves 50% of catalase peroxidase activity. The modified catalase-peroxidase offers high-level resistance to INH (Telenti A, et al., 1993) . So the biological activity of INH is reduced due to the mutation in InhA. Therefore, there is an urgent need for novel intervention strategies to target TB. Ajoene shows the potent inhibitory activity against the InhA protein. Ajoene (IUPAC name: (Z)-1-(prop-2-enyldisulfanyl)-3prop-2-enylsulfinylprop-1-ene) is the organosulfur compound, which contains sulfoxide and disulfide groups. Ajoene is reported for the anti-cancer activity (Roger, et al., 2008) , anti-bacterial activity (Torres, et al., 2012) , anti-fungal activity (Ledezma, et al., 2006) and wide possess wide range of biological applications. Development of Ajoene as a potential inhibitor would assist in effective medication for the disease with minimal or less toxic effects.
CONCLUSION
The present molecular docking studies provide insights into inhibition of InhA protein by phytoconstituents from A.sativum. Docking study suggest that Ajoene has a high binding affinity for InhA protein, which is much higher than the known inhibitor isoniazid. This study has led to the development of novel lead molecules for the treatment of Tuberculosis. Further these lead compounds can be used for designing more effective inhibitors of InhA. 
